Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Belldegrun Arie Create: Alert

All | News | Filings
Date FiledTypeDescription
03/24/2023 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 1,282,976 shares @ $0
Granted 994,800 options to buy @ $5.04, valued at $5M
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/16/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 160,000 options to buy @ $5, valued at $800k
09/02/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 3,241 options to buy @ $5, valued at $16.2k
06/29/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Kronos Bio, Inc.
Txns: Granted 34,000 options to buy @ $3.53, valued at $120k
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $7.06, valued at $70.6k
04/01/2022 4/A Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Disposed of 4,710,120 shares @ $0
Acquired 4,710,120 shares @ $0
03/31/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Disposed of 4,710,121 shares @ $0
Acquired 4,710,121 shares @ $0
03/28/2022 3/A Belldegrun Arie (Director) has filed a Form 3/A on Ginkgo Bioworks Holdings, Inc.
03/25/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 1,458,333 options to buy @ $9.69, valued at $14.1M
02/17/2022 SC 13G/A Belldegrun Arie reports a 6.1% stake in KRONOS BIO, INC.
02/14/2022 SC 13G/A Belldegrun Arie reports a 5% stake in ALLOGENE THERAPEUTICS, INC.
01/14/2022 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Bought 155,039 shares @ $12.6, valued at $2M
09/20/2021 3 Belldegrun Arie (Director) has filed a Form 3 on Ginkgo Bioworks Holdings, Inc.
06/23/2021 4 Belldegrun Arie (Director) has filed a Form 4 on Kronos Bio, Inc.
Txns: Granted 20,600 options to buy @ $24.18, valued at $498.1k
06/09/2021 4/A Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 3,241 options to buy @ $5, valued at $16.2k
06/09/2021 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $17.98, valued at $179.8k
05/25/2021 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Exercised 379,066 options to buy @ $18.22, valued at $6.9M
04/22/2021 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 3,241 options to buy @ $5, valued at $16.2k
03/30/2021 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 53,635 shares @ $0
Granted 199,223 options to buy @ $33.78, valued at $6.7M
02/12/2021 SC 13G/A Belldegrun Arie reports a 4.6% stake in ALLOGENE THERAPEUTICS, INC.
10/16/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/08/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/10/2020 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $28.24, valued at $282.4k
06/04/2020 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Bought 40,000 shares @ $47, valued at $1.9M
Bought 106,382 shares @ $47, valued at $5M
03/20/2020 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 379,066 options to buy @ $18.22, valued at $6.9M
02/13/2020 SC 13G/A Belldegrun Arie reports a 6% stake in ALLOGENE THERAPEUTICS, INC.
02/13/2020 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
06/05/2019 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Granted 10,000 options to buy @ $34.83, valued at $348.3k
05/15/2019 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Disposed of 598,935 shares @ $0
Acquired 13,413 shares @ $0
04/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2019 4 Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.
Txns: Exercised 128,000 options to buy @ $4.02, valued at $514.6k
03/15/2019 4 Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 115,333 shares @ $0
Granted 195,133 options to buy @ $26.89, valued at $5.2M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy